Related Experiment Video
Updated: May 7, 2025
03:26
Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
1.5K
Management and Prevention of Neuromodulator Complications
Journal of Drugs in Dermatology : JDD
|January 6, 2025
Summary
Neuromodulators for cosmetic facial rejuvenation are safe, but complications like neutralizing antibodies and eyelid ptosis can occur. Experts discussed preventing these risks and managing ptosis with alpha adrenergic agonists.
Area of Science:
- Dermatology
- Cosmetic Science
Background:
- Neuromodulators are widely used for cosmetic facial rejuvenation.
- Despite a good safety record, potential complications exist, including neutralizing antibodies and eyelid ptosis.
Purpose of the Study:
- To review common neurotoxin complications in cosmetic use.
- To summarize strategies for minimizing complication risks.
Main Methods:
- A roundtable discussion with 5 experts was convened.
- Three presenters shared knowledge on neurotoxin complications.
Main Results:
- Common complications include lack of response from neutralizing antibodies and eyelid ptosis.
- Neutralizing antibodies can often be prevented by avoiding risk factors.
- Topical alpha adrenergic agonists may improve eyelid ptosis.
Conclusions:
- Cosmetic neuromodulator use is highly safe with rare serious adverse events.
- Awareness and prevention of risk factors are key to managing complications.
- Further discussion focused on managing specific adverse events like ptosis.
Related Concept Videos
01:26Anticholinesterase Agents: Poisoning and Treatment
727
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
727
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
350
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
350
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
546
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
546
01:31Skeletal Muscle Relaxants: Therapeutic Uses
436
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
436
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.3K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.3K
01:21Skeletal Muscle Relaxants: Adverse Effects
309
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
309